These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9048487)

  • 1. Detection of antibodies to melanocytes in vitiligo by western immunoblotting.
    Hann SK; Shin HK; Park SH; Reynolds SR; Bystryn JC
    Yonsei Med J; 1996 Dec; 37(6):365-70. PubMed ID: 9048487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients.
    Park YK; Kim NS; Hann SK; Im S
    J Dermatol Sci; 1996 Feb; 11(2):111-20. PubMed ID: 8869031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells.
    Cui J; Bystryn JC
    Arch Dermatol; 1995 Mar; 131(3):314-8. PubMed ID: 7887661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to normal human melanocytes in vitiligo.
    Naughton GK; Eisinger M; Bystryn JC
    J Exp Med; 1983 Jul; 158(1):246-51. PubMed ID: 6345714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation.
    Naughton GK; Eisinger M; Bystryn JC
    J Invest Dermatol; 1983 Dec; 81(6):540-2. PubMed ID: 6196421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo.
    Kroon MW; Kemp EH; Wind BS; Krebbers G; Bos JD; Gawkrodger DJ; Wolkerstorfer A; van der Veen JP; Luiten RM
    J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1172-5. PubMed ID: 22404127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes.
    Li YL; Yu CL; Yu HS
    J Invest Dermatol; 2000 Dec; 115(6):969-73. PubMed ID: 11121127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytolytic antibodies to melanocytes in vitiligo.
    Cui J; Arita Y; Bystryn JC
    J Invest Dermatol; 1993 Jun; 100(6):812-5. PubMed ID: 8496621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of antibodies to human melanoma cell in vitiligo by western blot analysis.
    Hann SK; Kim JB
    Yonsei Med J; 1995 Nov; 36(5):457-61. PubMed ID: 8546004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of serum anti-melanocyte antibodies and identification of related antigens in patients with vitiligo.
    Zhu MC; Liu CG; Wang DX; Zhan Z
    Genet Mol Res; 2015 Dec; 14(4):16060-73. PubMed ID: 26662399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of melanocytes in vitiligo results from antibody penetration.
    Ruiz-Argüelles A; Brito GJ; Reyes-Izquierdo P; Pérez-Romano B; Sánchez-Sosa S
    J Autoimmun; 2007 Dec; 29(4):281-6. PubMed ID: 17888626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antibodies to human melanoma cells in vitiligo and alopecia areata by Western blot analysis.
    Hann SK; Koo SW; Kim JB; Park YK
    J Dermatol; 1996 Feb; 23(2):100-3. PubMed ID: 8839236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of vitiligo antigens.
    Cui J; Arita Y; Bystryn JC
    Pigment Cell Res; 1995 Feb; 8(1):53-9. PubMed ID: 7792255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of pigment cell antigens defined by vitiligo antibodies.
    Cui J; Harning R; Henn M; Bystryn JC
    J Invest Dermatol; 1992 Feb; 98(2):162-5. PubMed ID: 1370675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo.
    Harning R; Cui J; Bystryn JC
    J Invest Dermatol; 1991 Dec; 97(6):1078-80. PubMed ID: 1748818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo.
    Yu HS; Kao CH; Yu CL
    J Invest Dermatol; 1993 Jun; 100(6):823-8. PubMed ID: 8496622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vitiligo antigen on a revertant line of hamster melanoma cells.
    Naughton GK; Lipkin G; Bystryn JC
    J Invest Dermatol; 1984 Nov; 83(5):317-9. PubMed ID: 6386993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of serum autoantibodies to melanocyte and correlation between melanoma antigen recognized by T-cells and vitiligo in children].
    Chen JP; Li HP; Jin SH; Zhang JT; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2107-8, 2111. PubMed ID: 19861278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.
    van Geel NA; Mollet IG; De Schepper S; Tjin EP; Vermaelen K; Clark RA; Kupper TS; Luiten RM; Lambert J
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):375-84. PubMed ID: 20370855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.